Vimarsana
Biggest News Aggregation in the World

Peter Sackey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Sackey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Sackey Today - Breaking & Trending Today

Sedana Medical completes patient recruitment for its clinical program in the US - Vimarsana News

Sedana Medical completes patient recruitment for its clinical program in the US

/PRNewswire/ -- Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the...

Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US - Vimarsana News

Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US

/PRNewswire/ -- Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the...

Sedana Medical announces enrolment of first patient in US clinical program - Vimarsana News

Sedana Medical announces enrolment of first patient in US clinical program

/PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the first patient has been enrolled in the company's US clinical studies....

Sedana Medical announces enrolment of first patient in US clinical program - Vimarsana News

Sedana Medical announces enrolment of first patient in US clinical program

/PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the first patient has been enrolled in the company's US clinical studies....

Sedana Medical announces intention to carry out a directed share issue of approximately 600 MSEK - Vimarsana News

Sedana Medical announces intention to carry out a directed share issue of approximately 600 MSEK

STOCKHOLM, Dec. 2, 2021 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) ("Sedana Medical" or "Company") hereby announces the Company's intention to, by exercise of the authorisation